Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series

The frequency of using rituximab to treat refractory nephrotic syndrome has recently been increasing, and the conventional dose of rituximab used to treat it, 375 mg/m2 body surface area once weekly for 4 weeks, has been modelled on the chemotherapy regimen for B-cell non-Hodgkin’s lymphoma. The dos...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ryosuke Usui, Yohei Tsuchiya, Kosaku Nitta, Minako Koike
Materialtyp: Artigo
Språk:Inglês
Publicerad: Karger Publishers 2018-10-01
Serie:Case Reports in Nephrology and Dialysis
Ämnen:
Rituximab
Refractory nephrotic syndrome
Steroid-dependent nephrotic syndrome
Länkar:https://www.karger.com/Article/FullText/493189
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk